EATONTOWN, N.J.--(BUSINESS WIRE)--Flexible Stenting Solutions, Inc. (FSS), a leading developer of next generation peripheral arterial, venous, neurovascular and biliary stents, announced today the successful implantation of its 200 mm FlexStent® Femoropopliteal Self Expanding Stent System by Dr. Andrew Holden at Auckland City Hospital in New Zealand. With the addition of the 200 mm length FlexStent® Femoropopliteal Self Expanding Stent System under CE Mark (Conformite Europeene), stent sizes now include a complete matrix of 5, 6, 7 and 8 mm diameters with lengths ranging from 30 to 200 mm in a 6 French delivery system.
